Armata Pharmaceuticals (ARMP) Assets Average (2014 - 2026)

Armata Pharmaceuticals has disclosed Assets Average across 13 years of filings, most recently posting $79.9 million for Q2 2026.

• In Q2 2026, Assets Average fell 4.93% year-over-year to $79.9 million; the TTM figure through Jun 2026 stood at $79.9 million (down 4.93% YoY), while the FY2025 annual figure was $81.7 million, down 11.62% from the prior year.
• Assets Average came in at $79.9 million for Q2 2026 at Armata Pharmaceuticals, up from $73.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $114.3 million in Q2 2024 to a low of $73.3 million in Q1 2026.
• Average Assets Average over 5 years is $95.3 million, with a median of $95.6 million recorded in 2022.
• Year-over-year, Assets Average jumped 113.15% in 2022 and declined 26.51% in 2025.
• Over 5 years, Assets Average stood at $94.4 million in 2022, then gained by 11.87% to $105.6 million in 2023, then slipped by 12.53% to $92.3 million in 2024, then fell by 9.9% to $83.2 million in 2025, then decreased by 4.0% to $79.9 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $79.9 million in Q2 2026, $73.3 million in Q1 2026, and $83.2 million in Q4 2025.